 |
 |
This MeReC Bulletin summarises the NICE guidance on lipid modification and addresses some important supplementary clinical questions.
The most recent MeReC Bulletin: Lipid-modifying treatment (Vol. 19, No. 3) is now available. This is can be read online, and a print-friendly version (pdf) can also be downloaded. Note that we are no longer distributing paper copies of MeReC Bulletins.
The Bulletin:
- addresses the similarities and differences between NICE guidance for people with and without type 2 diabetes
- provides clarification on NICE’s recommendations regarding thresholds for intensifying treatment
- discusses the evidence base for high-intensity statins, for rosuvastatin and for ezetimibe▼, the reliability of single cholesterol measurements, and the side effects of statins.
MyNPC
To be kept up to date with all MeReC publications, and other NPC news and outputs, make sure you are signed up to NPC Email updates. You can personalise your account, so that you receive information only on what is of interest to you. If you are already signed up and want to amend your details or interests, you can do so at any time.
Feedback
Please comment on this blog in the NPC discussion rooms, or using our feedback form